| Browse All

Pelthos Therapeutics Inc. (PTHS)

Healthcare | Biotechnology | Durham, United States | NYSE American
23.00 USD +0.05 (0.218%) ⇧ (April 21, 2026, 4 p.m. EDT)

Short-term:★★★☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | April 18, 2026, 10:22 p.m. EDT

PTHS is a high-risk, speculative biotech play with a 'strong buy' analyst backdrop but deteriorating fundamentals (negative EBITDA, heavy losses) and no dividend support, resulting in zero long-term safety and neutral short-term momentum despite recent price stabilization near the 50-day average.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.049779
AutoETS0.049779
MSTL0.052081
AutoTheta0.053128

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 58%
H-stat 0.41
Ljung-Box p 0.000
Jarque-Bera p 0.003
Excess Kurtosis 1.71
Attribute Value
Sector Healthcare
Debt to Equity Ratio 89.576
Revenue per Share 8.931
Market Cap 77,177,488
Forward P/E -219.05
Beta 3.99
Profit Margins -257.93%
Previous Name Chromocell Therapeutics Corporation
Website https://pelthos.com

Info Dump

Attribute Value
52 Week Change 0.6788322
Address1 4,020 Stirrup Creek Drive
Address2 Suite 110
All Time High 60.0
All Time Low 4.5
Ask 0.0
Ask Size 200
Average Analyst Rating 1.1 - Strong Buy
Average Daily Volume10 Day 15,890
Average Daily Volume3 Month 8,206
Average Volume 8,206
Average Volume10Days 15,890
Beta 3.994
Bid 0.0
Bid Size 200
Book Value 12.021
City Durham
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 23.0
Current Ratio 2.055
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 23.14
Day Low 22.9
Debt To Equity 89.576
Display Name Pelthos Therapeutics
Earnings Call Timestamp End 1,773,921,600
Earnings Call Timestamp Start 1,773,921,600
Earnings Timestamp 1,773,923,400
Earnings Timestamp End 1,778,848,200
Earnings Timestamp Start 1,778,848,200
Ebitda -29,123,000
Ebitda Margins -1.73403
Enterprise To Ebitda -3.229
Enterprise To Revenue 5.599
Enterprise Value 94,032,488
Eps Current Year -10.95333
Eps Forward -0.105
Eps Trailing Twelve Months -23.04
Esg Populated 0
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 22.70214
Fifty Day Average Change 0.2978592
Fifty Day Average Change Percent 0.013120313
Fifty Two Week Change Percent 67.88322
Fifty Two Week High 54.29
Fifty Two Week High Change -31.29
Fifty Two Week High Change Percent -0.57634926
Fifty Two Week Low 9.0
Fifty Two Week Low Change 14.0
Fifty Two Week Low Change Percent 1.5555556
Fifty Two Week Range 9.0 - 54.29
Financial Currency USD
First Trade Date Milliseconds 1,708,093,800,000
Float Shares 1,345,975
Forward Eps -0.105
Forward P E -219.04762
Free Cashflow -24,652,500
Full Exchange Name NYSE American
Full Time Employees 92
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.68943
Gross Profits 11,579,000
Has Pre Post Market Data 1
Held Percent Insiders 0.56154996
Held Percent Institutions 0.32884
Implied Shares Outstanding 3,355,543
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,751,414,400
Last Split Factor 1:10
Long Business Summary Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Long Name Pelthos Therapeutics Inc.
Market us_market
Market Cap 77,177,488
Market State PRE
Max Age 86,400
Message Board Id finmb_1803540075
Most Recent Quarter 1,767,139,200
Name Change Date 2,026-04-20
Net Income To Common -43,319,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 77,177,489
Number Of Analyst Opinions 7
Open 23.0
Operating Cashflow -22,590,000
Operating Margins -1.2784101
Payout Ratio 0.0
Phone 919 908 2400
Prev Name Chromocell Therapeutics Corporation
Previous Close 22.95
Price Eps Current Year -2.099818
Price Hint 2
Price To Book 1.9133184
Price To Sales Trailing12 Months 4.595266
Profit Margins -2.5792801
Quick Ratio 1.032
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.14286
Region US
Regular Market Change 0.0499992
Regular Market Change Percent 0.217862
Regular Market Day High 23.14
Regular Market Day Low 22.9
Regular Market Day Range 22.9 - 23.14
Regular Market Open 23.0
Regular Market Previous Close 22.95
Regular Market Price 23.0
Regular Market Time 1,776,801,600
Regular Market Volume 17,602
Return On Assets -0.29795
Return On Equity -2.3955
Revenue Per Share 8.931
Sand P52 Week Change 0.3140242
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 3,355,543
Shares Percent Shares Out 0.0218
Shares Short 73,037
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 80,653
Short Name Pelthos Therapeutics Inc.
Short Percent Of Float 0.0458
Short Ratio 18.82
Source Interval 15
State NC
Symbol PTHS
Target High Price 75.0
Target Low Price 48.0
Target Mean Price 57.14286
Target Median Price 55.0
Total Cash 17,973,000
Total Cash Per Share 5.356
Total Debt 34,828,000
Total Revenue 16,795,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -23.04
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 25.58332
Two Hundred Day Average Change -2.5833206
Two Hundred Day Average Change Percent -0.10097675
Type Disp Equity
Volume 17,602
Website https://pelthos.com
Zip 27,703